415 related articles for article (PubMed ID: 25701034)
1. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery.
Yang Y; Yang Y; Xie X; Wang Z; Gong W; Zhang H; Li Y; Yu F; Li Z; Mei X
Biomaterials; 2015 Apr; 48():84-96. PubMed ID: 25701034
[TBL] [Abstract][Full Text] [Related]
2. Photolabile-caged peptide-conjugated liposomes for siRNA delivery.
Xie X; Yang Y; Yang Y; Mei X
J Drug Target; 2015; 23(9):789-99. PubMed ID: 25675844
[TBL] [Abstract][Full Text] [Related]
3. A photo-responsive peptide- and asparagine-glycine-arginine (NGR) peptide-mediated liposomal delivery system.
Xie X; Yang Y; Yang Y; Zhang H; Li Y; Mei X
Drug Deliv; 2016 Sep; 23(7):2445-2456. PubMed ID: 25693640
[TBL] [Abstract][Full Text] [Related]
4. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.
Lin W; Xie X; Yang Y; Liu H; Fu X; Chen Y; Liu H; Yang Y
J Pharm Pharmacol; 2015 Sep; 67(9):1215-31. PubMed ID: 25880614
[TBL] [Abstract][Full Text] [Related]
5. A near-infrared two-photon-sensitive peptide-mediated liposomal delivery system.
Yang Y; Yang Y; Xie X; Cai X; Wang Z; Gong W; Zhang H; Li Y; Mei X
Colloids Surf B Biointerfaces; 2015 Apr; 128():427-438. PubMed ID: 25766920
[TBL] [Abstract][Full Text] [Related]
6. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
7. Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery.
Lin W; Xie X; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
J Drug Target; 2016; 24(2):134-46. PubMed ID: 26176270
[TBL] [Abstract][Full Text] [Related]
8. Dual stimulus of hyperthermia and intracellular redox environment triggered release of siRNA for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Xu X; Xia X; Wang H; Li L; Dong W; Ma P; Liu Y
Int J Pharm; 2016 Jun; 506(1-2):158-73. PubMed ID: 27106526
[TBL] [Abstract][Full Text] [Related]
9. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy.
Yang Y; Xie X; Yang Y; Zhang H; Mei X
J Pharm Sci; 2015 Apr; 104(4):1328-39. PubMed ID: 25630979
[TBL] [Abstract][Full Text] [Related]
10. Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy.
Takara K; Hatakeyama H; Kibria G; Ohga N; Hida K; Harashima H
J Control Release; 2012 Aug; 162(1):225-32. PubMed ID: 22728515
[TBL] [Abstract][Full Text] [Related]
11. Efficient siRNA Delivery Using Novel Cell-Penetrating Peptide-siRNA Conjugate-Loaded Nanobubbles and Ultrasound.
Xie X; Lin W; Li M; Yang Y; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
Ultrasound Med Biol; 2016 Jun; 42(6):1362-74. PubMed ID: 27012462
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of CPP decorated doxorubicin and CPP decorated siRNA by NGR-modified nanobubbles for improving anticancer therapy.
Ma R; Nai J; Zhang J; Li Z; Xu F; Gao C
Pharm Dev Technol; 2021 Jul; 26(6):634-646. PubMed ID: 33843423
[TBL] [Abstract][Full Text] [Related]
13. PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer.
Xiang B; Dong DW; Shi NQ; Gao W; Yang ZZ; Cui Y; Cao DY; Qi XR
Biomaterials; 2013 Sep; 34(28):6976-91. PubMed ID: 23777916
[TBL] [Abstract][Full Text] [Related]
14. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
[TBL] [Abstract][Full Text] [Related]
15. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.
Yang ZZ; Li JQ; Wang ZZ; Dong DW; Qi XR
Biomaterials; 2014 Jun; 35(19):5226-39. PubMed ID: 24695093
[TBL] [Abstract][Full Text] [Related]
16. Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake.
Takara K; Hatakeyama H; Ohga N; Hida K; Harashima H
Int J Pharm; 2010 Aug; 396(1-2):143-8. PubMed ID: 20457236
[TBL] [Abstract][Full Text] [Related]
17. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
Kibria G; Hatakeyama H; Harashima H
Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy.
Chen Y; Wu JJ; Huang L
Mol Ther; 2010 Apr; 18(4):828-34. PubMed ID: 20068551
[TBL] [Abstract][Full Text] [Related]
19. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
[TBL] [Abstract][Full Text] [Related]
20. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]